Updated Jan 25, 2021 | 08:24 IST
The Tata Group which formed a company called Tata Medical and Diagnostics is likely to join hands with the CSIR to carry out clinical trials of Moderna’s vaccine candidate in India. Tatas may forge partnership with Moderna to launch Covid-19 vaccine in India. | Photo Credit: BCCL
New Delhi: Tata Medical and Diagnostics, the healthcare unit of the Tata Group, is reportedly in early talks with Moderna, an American biotechnology company, for a tie-up to roll out anti-coronavirus vaccine in India. It is worth noting that in November last year the Tata Group had launched a Covid-19 test kit that gives results in under an hour and as precise as the RT-PCR method. On January 16, India kicked off the world s largest immunisation campaign to bring the pandemic under control.
Share:
Indian conglomerate Tata Sons are in discussion with
Moderna Inc (NASDAQ: MRNA) for a partnership with its healthcare unit Tata Medical & Diagnostics, the Economic Times reported on Monday.
What Happened: Tata Medical & Diagnostics could team up with the Indian government s key R&D organization, the Council of Scientific & Industrial Research, to launch and carry out clinical trials for Moderna s COVID-19 vaccine candidate in India, Economic Times reported citing sources familiar with the matter.
India mandates foreign companies to conduct bridging phase-3 trials locally with Indian volunteers, even if the vaccine is approved outside India.
Related News:
Why It Matters: Moderna received funding from World Health Organization s (WHO) COVAX facility to develop its COVID-19 mRNA vaccine and aims to equitably distribute 2 billion doses in low-and middle-income countries, including India, by the end of 2021.
Elon Musk will give away $100 million for this, but what is Carbon Capture and why is it relevant?
Injecting carbon dioxide for EoR is a widely-used technology by oil and gas companies globally. January 22, 2021 / 01:50 PM IST
The term Carbon Capture caught the attention of social media on January 22, after the world s richest man and Tesla Inc chief Elon Musk announced a prize of $100 million for the best Carbon Capture technology. Though India is still in nascent stages as far as Carbon Capture is concerned, some companies are already using this technology in their industrial units.
What is Carbon Capture?
It is the process through which carbon dioxide is captured from large emission sources, thereby recycling it for other purposes and reducing emissions. According to experts, Carbon Capture is not new technology, but it got attention recently owing to the renewed focus on climate change.
CCMB-Keralaâs Arya Vaidya Sala agreement to assess Ayurvedaâs efficacy against COVID-19
AVS is a 118-years old charitable institution headquartered at Kottakkal in Kerala, which has been engaged in practice and propagation of Ayurveda. India is looking to find Ayurveda alternative to COVID-19 vaccine. (Photo: Reuters)
Share
Updated: Jan 1, 2021, 08:05 PM IST
The centuries old tried-and-proven Indian Ayurveda science is being tapped for potential formulation to fight coronavirus. In a very interesting development, the CSIR (Council of Scientific & Industrial Research) and CCMB (Centre for Cellular and Molecular Biology), Hyderabad, has entered into an agreement with Kerala-based Arya Vaidya Sala (AVS), Kottakkal, to check the efficacy of Ayurvedic formulations in the fight against coronavirus SARS-CoV-2.
Fight against coronavirus an example Atmanirbhar India: Harsh Vardhan hindustantimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hindustantimes.com Daily Mail and Mail on Sunday newspapers.